Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat
about
Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemiaColony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemiaThe multi-differentiation potential of peripheral blood mononuclear cellsFactors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.Prolonged ex vivo culture of cord blood CD34(+) cells facilitates myeloid and megakaryocytic engraftment in the non-obese diabetic severe combined immunodeficient mouse model.Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technologyCytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis.Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials.Progress in haematopoietic stem cell transplantation for multiple myeloma.Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation.NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.Dose and schedule effect of G-GSF for stem cell mobilization in healthy donors for allogeneic transplantation.Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies.Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignanciesAre predictive factors clinically useful in bone marrow transplantation?Risk factors for acute GVHD and survival after hematopoietic cell transplantationDurable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effectsAllogeneic hematopoietic cell transplantation for MDS: for whom, when and how?Optimization of allogeneic transplant conditioning: not the time for dogma.Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation.Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients.Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donors.Stem cells in hemato-oncology.Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.Clinical uses of GM-CSF, a critical appraisal and update.The impact of CD34+ cell dose on engraftment after SCTs: personalized estimates based on mathematical modeling.Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study.Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.Allogeneic haemopoietic cell transplants in Australia, 1996--a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow.Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back.Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas.Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma.Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease.Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis.Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose.
P2860
Q24202698-F3ADD4A2-C5D8-45BE-9334-4AA6811910DCQ24234458-EBC94036-D6D6-4F62-9FA6-48030C5EB438Q26852323-C5EB9E13-2CB3-4BAC-B322-7957BB21BC0BQ31893507-F323CE89-378F-4E30-86CD-A0806FCB66C1Q33338773-96D14565-9306-4981-808E-4AE422A61407Q33800486-6DAAC8B7-E5ED-438F-AEBD-EC74EB011E42Q33929670-6C513F37-CBDD-4D51-BD55-2D002D4E6005Q33971524-13D45701-2BE3-4663-9CE3-C35E94054DB3Q34022664-5E53C1AB-E128-4653-9CC2-2D15EC3AEDC4Q34066661-CA0D2890-FE04-47B0-A2A2-0B1CE06A30F6Q34078681-0B46496E-61C6-41AF-A22D-90EE1B283EE6Q34975536-0D1D24B1-C43C-4F90-B210-88F5EEAEBD67Q35083562-B6AE218A-B0E6-49F1-9AB7-7D092FB53744Q35133894-ADEB6565-1379-48C5-946D-8016DD4FB05BQ35561009-4D98078A-24C7-475C-A66D-D002ED9B8611Q35651735-2066AFB8-9456-49F3-A121-225F39419F4BQ35847785-4F94BB61-7B79-4721-AAB7-0C7F4304A765Q36020073-458BB488-7BA1-4B5F-82B6-7E8644DC7C60Q36380188-4C1A8570-84DA-4C5F-8DA8-5220C55C5772Q36431041-69DC66D4-E345-4A08-B487-B6E2551AABCDQ36556498-1168138A-9A49-43DC-A1A8-987729BB4774Q37145279-6C19B12D-4735-4F6E-B1C7-0313FD8A7852Q37572533-A7DE4357-208C-4186-A1DB-668BCAE0D3A0Q38517394-126DA279-3905-4F97-A3E8-44A3B435123DQ41902244-377D2614-8E55-4329-8085-7878E89AD849Q42518728-74D9534A-180E-454A-A203-5DEC901C6AE8Q43068695-762D8364-E811-4EE7-8F11-2A995FF2F919Q43417842-A2AF66BD-CC4D-46EF-836E-A03E724DBC7BQ43539741-7F90A9A0-3C10-4CD9-8142-3F74660A9316Q43661040-0706FCC7-6046-47C9-B362-F8A559405F8DQ43703219-A80BAB47-47A1-4C03-9E9B-8CD8872E6C88Q43703956-5D90A998-2070-4500-8694-E8D95068C2C7Q44024542-F1C264C1-714D-462F-BA5E-8BBB41F57CF1Q44117304-AC877E2E-3E26-451C-A0D0-9B1BEED2AB7BQ44119537-2A30426F-D3C6-40D9-993B-B72EC1FB0EB6Q44427173-D79C0D64-9156-4D61-9B8C-14708A4F78BFQ44603435-4A23660D-9AC0-4182-AABC-FDCF620AA2F1Q45111052-2CBE32D5-0B5D-49BA-9C5C-0D99FFCC4B99Q45851521-C0E9695D-F0E9-402B-8DFE-1F9CF864B887Q46434551-2DF6BAC4-F902-48FF-AC55-D62334BDFDCD
P2860
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Allogeneic bone marrow transpl ...... Blood and Marrow Transplantat
@en
Allogeneic bone marrow transpl ...... Blood and Marrow Transplantat
@nl
type
label
Allogeneic bone marrow transpl ...... Blood and Marrow Transplantat
@en
Allogeneic bone marrow transpl ...... Blood and Marrow Transplantat
@nl
prefLabel
Allogeneic bone marrow transpl ...... Blood and Marrow Transplantat
@en
Allogeneic bone marrow transpl ...... Blood and Marrow Transplantat
@nl
P2093
P356
P1476
Allogeneic bone marrow transpl ...... Blood and Marrow Transplantat
@en
P2093
Apperley JF
Bacigalupo A
Bourquelot P
Frickhofen N
Hasenclever D
P2888
P304
P356
10.1038/SJ.BMT.1701234
P407
P577
1998-05-01T00:00:00Z